BioInvent International

BioInvent International (BINV) investor relations material

BioInvent International Q2 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.

Q2 2026 earnings summary27 Aug, 2026

Executive summary

Achieved significant clinical milestones in Q2 2026, including strong efficacy data for BI-1808 in ovarian cancer and CTCL, and BI-1206 in NHL, with results presented at ASCO and EHA 2026.
BI-1808 received FDA Fast Track Designation for ovarian cancer after the period, validating its development strategy and potential in a high unmet need area.
Two successful KOL events highlighted the clinical and commercial potential of BI-1808 and BI-1206 in oncology.

Financial highlights

Q2 2026 net sales were SEK 12.8 million, down from SEK 198.1 million in Q2 2025, mainly due to a one-time royalty sale in the prior year.
Profit/loss after tax for Q2 2026 was SEK -122.9 million, compared to SEK 38.8 million in Q2 2025; for H1 2026, SEK -242.1 million vs. SEK -77.8 million in H1 2025.
Liquid funds and current investments at June 30, 2026, were SEK 340.8 million, down from SEK 797.5 million a year earlier.
Cash flow from operating activities for H1 2026 was SEK -244.8 million.

Outlook and guidance

Additional data from the BI-1808 plus pembrolizumab expansion cohort in ovarian cancer expected in H2 2026.
Initiation of BI-1808 Phase 2a triplet study in ovarian cancer and first readout from BI-1206 plus pembrolizumab in NSCLC and uveal melanoma anticipated in H2 2026.
Company is financed into late Q1 2027 but faces material uncertainty regarding future financing, with efforts ongoing to secure funding in H2 2026.

Partial view of Summaries dataset, powered by Quartr API

AI can get things wrong. Verify important information.

Research faster. Power your platform.

Latest events from BioInvent International

View more events

Next BioInvent International earnings date

Q3 202629 Oct, 2026

Companies

BioInvent International

Your earnings  season toolkit.

Download

Free on both iOS & Android.

Next BioInvent International earnings date

Q3 202629 Oct, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.

Leroy DaleyApp Store

One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.

Eferix Drawings Google Play

This is genuinely one of the cleanest and fastest finance apps out there to track the market.

anuj283App Store

Leroy DaleyApp Store

One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.

Eferix Drawings Google Play

This is genuinely one of the cleanest and fastest finance apps out there to track the market.

anuj283App Store

I can't remember the last time an app had such a positive impact on my investment process.

@ankurshah47_ x.com

Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.

Amina0781App Store

Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.

@theshortbearx.com

I can't remember the last time an app had such a positive impact on my investment process.

@ankurshah47_ x.com

Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.

Amina0781App Store

Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.

@theshortbearx.com

I’m actually shocked at just how much I like Quartr. If you’re an analyst & need a strong web tool + mobile app that syncs properly, saves you from manually dialing into calls.

@endthepods x.com

A must have for every investor. includes all quarterly reports with earnings calls and transcripts in single app

Abdulla AlnaamaGoogle Play